Table 2.
Mortality at 7 days | Mortality at 30 days | Mortality at 90 days | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Alive (N = 4,292) | Death (N = 340) | p | Alive (N = 3,504) | Death (N = 1,128) | P | Alive (N = 3,174) | Death (N = 1,458) | p | ||
Sex: | Male | 1,478 (34.44%) | 143 (42.06%) | 0.005* | 1,162 (33.16%) | 459 (40.69%) | <0.001* | 1,034 (32.58%) | 587 (40.26%) | <0.001* |
Female | 2,814 (65.56%) | 197 (57.94%) | 2,342 (66.84%) | 669 (59.31%) | 2,140 (67.42%) | 871 (59.74%) | ||||
Age: | 65–79 | 726 (16.92%) | 34 (10.00%) | 0.001* | 657 (18.75%) | 103 (9.13%) | <0.001* | 620 (19.53%) | 140 (9.60%) | <0.001* |
≥80 | 3,566 (83.08%) | 306 (90.00%) | 2,847 (81.25%) | 1,025 (90.87%) | 2,554 (80.47%) | 1,318 (90.40%) | ||||
SE level: | Mutualist | 153 (3.56%) | 7 (2.06%) | 0.328 | 138 (3.94%) | 22 (1.95%) | 0.003* | 130 (4.11%) | 30 (2.05%) | 0.001* |
Pensioner <18,000€/year | 3,359 (78.26%) | 280 (82.35%) | 2,748 (78.42%) | 891 (78.99%) | 2,468 (77.76%) | 1,171 (80.32%) | ||||
Pensioner ≥18,000€/year | 573 (13.35%) | 38 (11.18%) | 448 (12.79%) | 163 (14.45%) | 415 (13.07%) | 196 (13.44%) | ||||
Free medicines | 170 (3.96%) | 14 (4.12%) | 136 (3.88%) | 48 (4.26%) | 128 (4.04%) | 56 (3.82%) | ||||
Other | 37 (0.86%) | 1 (0.29%) | 34 (0.97%) | 4 (0.35%) | 33 (1.04%) | 5 (0.34%) | ||||
Number of diseases (a) | 6.00 (4.00;8.00) | 6.00 (5.00;8.00) | 0.012* | 6.00 (4.00;8.00) | 6.00 (5.00;8.00) | 0.003* | 6.00 (4.00;8.00) | 6.00 (5.00;8.00) | 0.004* | |
Complexity (a) | 3.00 (2.00;4.00) | 3.00 (2.00;4.00) | 0.015* | 3.00 (2.00;4.00) | 3.00 (2.00;4.00) | <0.001* | 3.00 (2.00;4.00) | 3.00 (2.00;4.00) | 0.003* | |
Diagnosis: | Diabetes mellitus | 1,068 (25.72%) | 98 (29.25%) | 0.176 | 850 (25.20%) | 316 (28.37%) | 0.040* | 771 (25.30%) | 395 (27.45%) | 0.134 |
Obesity | 535 (12.89%) | 37 (11.04%) | 0.375 | 448 (13.28%) | 124 (11.13%) | 0.070 | 410 (13.45%) | 162 (11.26%) | 0.045* | |
Hypertension | 3,001 (72.28%) | 236 (70.45%) | 0.512 | 2,453 (72.72%) | 784 (70.38%) | 0.140 | 2,216 (72.70%) | 1,021 (70.95%) | 0.236 | |
Stroke | 599 (14.43%) | 55 (16.42%) | 0.361 | 475 (14.08%) | 179 (16.07%) | 0.114 | 427 (14.01%) | 227 (15.77%) | 0.129 | |
Ischemic heart disease | 419 (10.09%) | 41 (12.24%) | 0.249 | 315 (9.34%) | 145 (13.02%) | 0.001* | 293 (9.61%) | 167 (11.61%) | 0.045* | |
Heart failure | 514 (12.38%) | 64 (19.10%) | 0.001* | 399 (11.83%) | 179 (16.07%) | <0.001* | 359 (11.78%) | 219 (15.22%) | 0.002* | |
COPD | 412 (9.92%) | 41 (12.24%) | 0.208 | 321 (9.52%) | 132 (11.85%) | 0.029* | 281 (9.22%) | 172 (11.95%) | 0.005* | |
Chronic kidney disease | 1,147 (27.63%) | 111 (33.13%) | 0.036* | 894 (26.50%) | 364 (32.68%) | <0.001* | 797 (26.15%) | 461 (32.04%) | <0.001* | |
Depression | 1,167 (28.11%) | 102 (30.45%) | 0.394 | 949 (28.14%) | 320 (28.73%) | 0.733 | 867 (28.44%) | 402 (27.94%) | 0.751 | |
Dementia | 1,372 (33.04%) | 122 (36.42%) | 0.230 | 1,086 (32.20%) | 408 (36.62%) | 0.007* | 968 (31.76%) | 526 (36.55%) | 0.002* |
Sociodemographic and clinical characteristics.
N, number; SE socioeconomic; p, statistical significance; a, results expressed as median and interquartile range; COPD, chronic obstructive pulmonary disease.
*Statistically significant results.